News

The $42.6 million Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study directly compared second-generation antipsychotics with older drugs. Total monthly health costs were up to 30% lower for

VCG & Associates is an independent strategic marketing and contract services provider specializing in working with emerging pharmaceutical, biotech and technology companies. New Pharmaceutical Strategies (NPS) provides consulting

“The acquisition of Be-Tabs results in considerable synergies and further strengthens Ranbaxy’s foothold in South Africa. It reinforces our position by expanding our portfolio in a key market

Patients with CCR5-tropic HIV-1 have limited or no approved treatment options due to resistance or intolerance. The treatment maraviroc is in a new class of investigational HIV drugs

In September 2005, Astellas Pharma filed a marketing authorization application for the Eligard six-month product with the German pharmaceutical regulatory authority, BfArM. Eligard is already approved in Germany

The results shows that adding inhaled iloprost to treatment with bosentan increases exercise capability, reduces clinical deterioration and, in some cases, improves diagnostic functional class by one stage.

The preliminary research indicates that patients achieved a statistically significant improvement in pain from osteoarthritis of the knee over 26 weeks compared with those using placebo. Currently Synvisc

This compound mifepristone (RU486) prevented the tumors by inhibiting progesterone, a hormone involved with the female reproductive cycle, in breast tissue cells. Mifepristone is designed to abort pregnancy

The contracts cover the next three years until 2009, with the awarded amount growing over those three years. Following a WHO prequalification in September 2006 the combination vaccine